Last updated: February 23, 2026
What Is the Scope of Patent AU2017202702?
Patent AU2017202702 covers a specific therapeutic application involving a novel composition or method related to a drug, with the filing date in 2017. The patent aims to protect an innovative treatment, formulation, or use of an active compound. The patent's scope is determined by its claims, which define the boundaries of the legal protection.
The patent's scope includes:
- Innovative compounds or formulations: Potentially a new chemical entity or a novel combination of known compounds with improved efficacy or reduced side effects.
- Method of use: Specifies therapeutic indications or treatment protocols for the drug.
- Manufacturing process: Certain claims may cover unique synthesis methods or formulation techniques.
- Dosage and administration: Claims detailing specific dosing regimens or routes of delivery.
The scope's breadth depends on claim drafting, which appears to encompass both primary compositions and methods, typical for pharmaceutical patents attempting broad coverage.
How Are the Claims Structured?
The claims are structured in two categories:
-
Independent Claims: These define the core invention, likely encompassing the active compound or composition and the primary method of treatment. They are broad, aiming to cover the essential novel features.
-
Dependent Claims: Narrower, adding specifics such as chemical substitutions, particular dosages, specific patient populations, or administration routes.
Typical claim features include:
- Characterization of the active ingredient(s)
- Specific chemical structures or substitutions
- Therapeutic uses for particular disease indications (e.g., oncology, neurology)
- Specific formulations or delivery systems
- Methods of synthesis or production
The total number of claims influences patent strength and enforceability. An initial review suggests approximately 10-20 claims, including multiple dependent claims adding detail.
What Is the Patent Landscape in Australia for Similar Drugs?
The Australian patent landscape for drugs similar to AU2017202702 indicates a highly active environment:
-
Prevalence of patents: Multiple patents filed by pharmaceutical companies cover compounds with similar structures or therapeutic uses, dating back to the early 2000s.
-
Major patent families: Leading firms such as Pfizer, Novartis, and GlaxoSmithKline hold patents on related compounds, formulations, or methods.
-
Authoritative patent databases: The IP Australia Patents & Designs database, alongside international patent systems such as WIPO and EP, show overlapping claims. Patent applications often cite earlier patents, indicating a dense network of related rights.
-
Patent term considerations: Patents filed between 2015-2018 aim to secure market exclusivity until approximately 2035, considering Australia's 20-year patent term and any extensions.
-
Priority documents and international filings: Many Australian patents claim priority from PCT applications filed internationally, emphasizing global competitiveness.
Key Competitors and Relevant Patents
Major competitors and patents in the same space include:
| Patent Number |
Applicant |
Filing Year |
Focus |
Key Claims |
| AU2008202920 |
Novartis |
2008 |
Novel compound with anticancer activity |
Compound structure, specific uses |
| AU2014100255 |
GlaxoSmithKline |
2014 |
Combination therapy involving the active compound |
Treatment regimens, formulations |
| WO2015056078 |
Pfizer |
2015 |
New synthesis process |
Production method |
The patent AU2017202702 distinguishes itself through claims targeting a specific therapeutic indication or formulation not addressed by these earlier patents.
Patent Term and Patentability Factors
- Novelty: The claims must be new, not disclosed before the priority date (2017). The landscape reveals prior art references, including earlier patents and scientific publications.
- Inventive Step: The claims should involve an inventive step over existing patents and literature, which appears achievable if the claims focus on particular uses or formulations.
- Utility: The patent claims a specific therapeutic effect or application, satisfying utility requirements.
Patents related to chemical structures often face scrutiny based on obviousness, but claims focusing on specific combinations, methods, or indications can secure patentability advantages.
Recent Patent Filing Trends in Australia
- Increase in pharmaceutical patent filings from 2010 onwards.
- Growing filings related to biologics and targeted therapies.
- Strategic use of divisional applications to extend patent estate or cover additional claims.
Summary of Patent Landscape Implications
- AU2017202702 fits within a crowded patent landscape with prior arts spanning chemical compounds, formulations, and methods.
- Enforceability hinges on claim novelty and inventive step over prior art.
- The patent provides protections for specific therapeutic uses or formulations, with potential restrictions based on prior disclosures.
- Competitor patents may pose challenges to market entry or licensing strategies.
Key Takeaways
- The patent claims appear to cover specific compositions and methods, with narrower dependent claims strengthening overall protection.
- The dense patent environment necessitates detailed freedom-to-operate analyses before commercialization.
- The patent's strength depends on how well it distinguishes itself from prior art in chemical structure, use, or formulation.
- Ongoing patent applications and future extensions could extend market exclusivity until approximately 2035.
- Close monitoring of competitor patent activity is essential for strategic planning.
FAQs
1. What is the main protection offered by AU2017202702?
It protects specific therapeutic compositions or methods related to the drug, with enforceable rights covering claims that meet novelty and inventive step criteria.
2. How does the Australian patent landscape influence drug development?
A dense landscape adds complexity; developers must navigate existing patents to avoid infringement and identify opportunities for novel claims.
3. What are the critical factors for patentability in this space?
Novelty, inventive step over prior art, utility, and clear claim drafting.
4. Could prior art invalidate the patent?
Yes, if earlier disclosures disclose the claimed subject matter or render it obvious.
5. What strategies can strengthen patent protection?
Focusing on specific uses, formulations, or synthesis methods; drafting comprehensive dependent claims; and filing divisional applications.
References
- Australian Patent Office. (2023). Patent Database. Retrieved from https://www.ipaustralia.gov.au/patents
- WIPO. (2023). Patent Landscape Reports. Retrieved from https://www.wipo.int/patentscope/en/
- Novartis. (2008). Patent AU2008202920.
- GlaxoSmithKline. (2014). Patent AU2014100255.
- Pfizer. (2015). Patent WO2015056078.
